5 Best Healthcare Stocks Under $20 According to Michael Castor’s Sio Capital

4. Spruce BioSciences, Inc. (NASDAQ:SPRB)

Castor’ Stake Value: $7.25 million

Percentage of Michael Castor’s 13F Portfolio: 1.8%

Number of Hedge Fund Holders: 10

Stock Price as of September 23: $6.27

Spruce Biosciences, Inc. (NASDAQ:SPRB) is a late-stage biotechnology company that offers endocrinology services, and is involved in the development of medicines and therapies for the treatment of rare endocrine disorders. Ranked fourth on the list of the 10 best healthcare stocks under $20 according to Michael Castor’s Sio Capital, Spruce BioSciences, Inc. (NASDAQ:SPRB) has a market capitalization of $146.58 million.

At present, Michael Castor’s Sio Capital Management holds 647,239 shares of Spruce BioSciences, Inc. (NASDAQ:SPRB), worth over $7.25 million and representing 1.8% of the fund’s total portfolio. By the end of the second quarter of 2021, 10 hedge funds out of the 873 tracked by Insider Monkey held stakes in Spruce BioSciences, Inc. (NASDAQ:SPRB) worth roughly $72.7 million. This is compared to 8 hedge funds in the previous quarter with a total stake value of approximately $84 million.

For the second quarter of 2021, Spruce BioSciences, Inc. (NASDAQ:SPRB) reported earnings per share at -$0.50, falling short of the market estimates by $0.05.

Out of the hedge funds being tracked by Insider Monkey’s database, Illinois-based investment firm Citadel Investment Group is a leading shareholder in Spruce BioSciences, Inc. (NASDAQ:SPRB) with over 1.7 million shares worth more than $19 million.